谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Abstract P6 14 01: Final results of the TANIA randomized phase III trial of bevacizumab (BEV) after progression on 1st line BEV therapy for HER2 negative locally recurrent …

E Vrdoljak,N Marschner,C Zielinski,J Gligorov, J Cortes,F Puglisi,M Aapro,L Fallowfield, A Fontana,M Inbar,Z Kahan,A Welt,C Lévy,E Brain,X Pivot,C Putzu,A Gonzalez-Martin, K Ebel,V Easton,G von Minckwitz

Poster Session Abstracts（2016）

引用 0|浏览15
暂无评分
关键词
bevacizumab,recurrent/metastatic breast cancer,breast cancer,st-line
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要